Expertise in
4
conditions

Adrian S. Wagg

11350 83 Avenue, 
Edmonton, AB, CA 
Expertise in
4
conditions
11350 83 Avenue, 
Edmonton, AB, CA 

Overview

Adrian Wagg practices practicing medicine in Edmonton, Canada.

Mr. Wagg is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Frequent or Urgent Urination, Bowel Incontinence, and Stress Urinary Incontinence.

He is actively involved in clinical research, co-authoring 249 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

11350 83 Avenue, Edmonton, AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Post-market Cluster Randomized Controlled Trial of the Effect of the TENA SmartCare Change Indicator on Continence Care Efficiency and Skin Health in Long Term Care Facilities
A Post-market Cluster Randomized Controlled Trial of the Effect of the TENA SmartCare Change Indicator on Continence Care Efficiency and Skin Health in Long Term Care Facilities
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomised Cross Over Trial of Briefs With Tapes Versus Pull Ups for the Containment of Urinary Incontinence in Community Dwelling Older People Living With Mild to Moderate Dementia (CUPID)
A Randomised Cross Over Trial of Briefs With Tapes Versus Pull Ups for the Containment of Urinary Incontinence in Community Dwelling Older People Living With Mild to Moderate Dementia (CUPID)
Enrollment Status: Terminated
Publish Date: May 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomised, Controlled Trial of effectIveness of a Smart Sensor for Continence Care: the ARCTICC Study
A Randomised, Controlled Trial of effectIveness of a Smart Sensor for Continence Care: the ARCTICC Study
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Double Blind, Randomized Four Way Cross Over Study to Compare the Effect of Fesoterodine 4mg and 8mg Once Daily and Oxybutynin 5mg Twice Daily After Steady State Dosing Versus Placebo on Cognitive Function in Subjects With Overactive Bladder, Over the Age of 75 Years With Mild Cognitive Impairment
A Double Blind, Randomized Four Way Cross Over Study to Compare the Effect of Fesoterodine 4mg and 8mg Once Daily and Oxybutynin 5mg Twice Daily After Steady State Dosing Versus Placebo on Cognitive Function in Subjects With Overactive Bladder, Over the Age of 75 Years With Mild Cognitive Impairment
Enrollment Status: Completed
Publish Date: February 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
Supporting Healthy Aging by Peer Education and Support (SHAPES) - A Stepped-Wedge Cluster Randomized Trial
Supporting Healthy Aging by Peer Education and Support (SHAPES) - A Stepped-Wedge Cluster Randomized Trial
Enrollment Status: Completed
Publish Date: November 04, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
Phase 3 Cluster Randomised Trial Testing the Efficacy of a Continence Promotion Intervention to Improve Urinary Symptoms and Quality of Life, and Reduce Stigma and Falls in Older Community-dwelling Women With Untreated Incontinence
Phase 3 Cluster Randomised Trial Testing the Efficacy of a Continence Promotion Intervention to Improve Urinary Symptoms and Quality of Life, and Reduce Stigma and Falls in Older Community-dwelling Women With Untreated Incontinence
Enrollment Status: Completed
Publish Date: July 24, 2017
Intervention Type: Behavioral
Study Phase: Not Applicable
View 5 Less Clinical Trials

249 Total Publications

'I took the vaccine to protect myself': determinants of COVID-19 vaccine confidence in Indigenous communities in Northwest Territories, Canada.
'I took the vaccine to protect myself': determinants of COVID-19 vaccine confidence in Indigenous communities in Northwest Territories, Canada.
Journal: Health promotion international
Published: August 06, 2026

Frequently Asked Questions about Adrian S. Wagg

Is Adrian S. Wagg a top-rated expert for Urinary Incontinence?

MediFind is an objective health platform that identifies experts based on real-world data. Adrian S. Wagg is classified as an Elite expert for Urinary Incontinence, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Adrian S. Wagg participate in research or clinical trials?

Yes. Adrian S. Wagg has published 249 articles and abstracts on conditions like Urinary Incontinence. You can view a list of Adrian S. Wagg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wagg's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile